Our clients' stories

Emma case study

Emma, a legal officer at The Royal College of Nursing, tells her story on being the first employee in her team to share her diagnosis and how she found the strength to move forward.

James case study

James, a fibre engineer at BT, shares his journey and explains how our cancer support helped him practically and emotionally on his road to recovery.

Tarsem case study

Tarsem, a product manager at Novartis, outlines how Reframe helped him to regain confidence during his recovery from prostate cancer.

case-study-prostate-cancer

Colvin, a brand manager at Rymans Stationary, outlines how Reframe supported his recovery when other services couldn’t.

An avid triathlete

Antonio, a customer support director at Ivanti Software shares his bowel cancer story.

“[Suzanne] was very helpful in taking care of any problems or concerns I had and preventing them turning into major complications which could have delayed my recovery.”

Read Antonio's story

Customer testimonials

Unum

Glenn Thompson, chief distribution officer

“Reframe works alongside the vital hands-on medical treatment necessary to treat cancer, offering much-needed practical and emotional assistance which can reassure cancer patients at a very difficult time.”

Rugby Football Union

Paula Grant, People Director

“I know the Reframe service is classed as an employee benefit but for us it’s more than that; it’s a source of hope and continuity to help people get through a life-changing experience. We consider Reframe an essential component in how we support people and those around them when they are ill – on a par with things like enhanced sick pay.”

Unum

Ambika Fraser, head of propositions

“A diagnosis can be traumatic for everyone involved so the need to support those affected was clear to us. It’s one of the reasons why it’s been so well received by our clients and their employees.”

About us

Life has its ups and downs. That’s why we work alongside health services to ensure people understand their options and are supported beyond their clinical needs.

Read our story